This article is more than 5 years old. Information may no longer be current.
Cardiology Today's top articles posted in July
Click Here to Manage Email Alerts
Cardiology Today compiled a list of the top 5 stories posted to Healio.com/Cardiology in July.
This month, readers were most interested in new research on lipoprotein(a)-reducing antisense drugs, CT-derived fractional flow reserve, the link between reactive antitachycardia pacing and rates of AF progression, and much more.
Dose-ranging trial begins for antisense drug to reduce Lp(a)
Akcea Therapeutics, a subsidiary of Ionis Pharmaceuticals, announced that enrollment has commenced for a phase 2b dose-ranging trial to evaluate the antisense drug AKCEA-APO(a)-LRx in individuals with hyperlipoproteinemia(a) and established CVD.
Accuracy of FFR-CT varies in patients with myocardial ischemia
Diagnostic accuracy of CT-derived fractional flow reserve was high in extreme cases of myocardial ischemia but reduced in intermediate cases, researchers reported in JAMA Cardiology.
Reactive antitachycardia pacing therapy linked to lower AF progression rates
Reactive antitachycardia pacing therapy was associated with lower rates of atrial fibrillation in patients with pacemakers, defibrillators and resynchronization devices, according to research presented at EHRA Europace-Cardiostim 2017.
Biotronik announces FDA approval of ICD systems for patients with HF
Two implantable cardioverter defibrillator systems have been approved for patients with HF, according to a press release from Biotronik.
Healthful plant-based diet may decrease risk for CHD
Individuals who adhered to a healthful plant-based diet, including mainly plant-based foods with no animal-based foods and without refined grains, potatoes, sugar-sweetened beverages or fruit juices, had a decreased risk for CHD, according to a study published in the Journal of the American College of Cardiology.